Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0HYRZD
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
BAY-1862864
|
|||||
| Synonyms |
BAY 1862864; BAY1862864; CD22-Thorium-conjugate; Epratuzumab Th-227 conjugate; epratuzumab-227Th-conjugate; epratuzumab-Th227-conjugate
Click to Show/Hide
|
|||||
| Organization |
Bayer AG
|
|||||
| Drug Status |
Phase 1
|
|||||
| Indication |
In total 1 Indication(s)
Non Hodgkin lymphoma [ICD11:2B33]
Phase 1
|
|||||
| Antibody Name |
Epratuzumab
|
Antibody Info | ||||
| Antigen Name |
B-cell receptor CD22 (CD22)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Linker Name |
Undisclosed
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.